☰

Jennifer S. Guimbellot, MD PhD - Publications

Affiliations: 
2007 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Molecular Biology, Genetics
Tree Info Similar researchers PubMed Report error

12/31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Liu Z, Anderson JD, Natt J, Guimbellot JS. Culture and Imaging of Human Nasal Epithelial Organoids. Journal of Visualized Experiments : Jove. PMID 34978285 DOI: 10.3791/63064  0.315
2020 Hoppe JE, Guimbellot J, Martiniano SL, Toprak D, Davis C, Daines CL, Muhlebach MS, Esther CR, Dellon EP. Highlights From the 2019 North American Cystic Fibrosis Conference. Pediatric Pulmonology. PMID 32573948 DOI: 10.1002/Ppul.24919  0.328
2020 Liu Z, Anderson JD, Deng L, Mackay S, Bailey J, Kersh L, Rowe SM, Guimbellot JS. Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis. Genes. 11. PMID 32485957 DOI: 10.3390/Genes11060603  0.447
2020 Guimbellot JS, Ryan KJ, Anderson JD, Liu Z, Kersh L, Esther CR, Rowe SM, Acosta EP. Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32044246 DOI: 10.1016/J.Jcf.2020.01.011  0.335
2019 Liu Z, Mackay S, Gordon DM, Anderson JD, Haithcock DW, Garson CJ, Tearney GJ, Solomon GM, Pant K, Prabhakarpandian B, Rowe SM, Guimbellot JS. Co-cultured microfluidic model of the airway optimized for microscopy and micro-optical coherence tomography imaging. Biomedical Optics Express. 10: 5414-5430. PMID 31646055 DOI: 10.1364/Boe.10.005414  0.309
2018 Poore TS, Virella-Lowell I, Guimbellot JS. Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis. Pediatric Pulmonology. PMID 29790674 DOI: 10.1002/Ppul.24043  0.32
2018 Guimbellot J, Solomon GM, Baines A, Heltshe SL, VanDalfsen J, Joseloff E, Sagel SD, Rowe SM. Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutations. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29685811 DOI: 10.1016/J.Jcf.2018.04.004  0.357
2017 Guimbellot JS, Leach JM, Chaudhry IG, Quinney NL, Boyles SE, Chua M, Aban I, Jaspers I, Gentzsch M. Nasospheroids permit measurements of CFTR-dependent fluid transport. Jci Insight. 2. PMID 29202459 DOI: 10.1172/Jci.Insight.95734  0.382
2017 Guimbellot J, Sharma J, Rowe SM. Toward inclusive therapy with CFTR modulators: Progress and challenges. Pediatric Pulmonology. PMID 28881097 DOI: 10.1002/Ppul.23773  0.425
2009 Guimbellot JS, Erickson SW, Mehta T, Wen H, Page GP, Sorscher EJ, Hong JS. Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis. Bmc Medical Genomics. 2: 15. PMID 19320992 DOI: 10.1186/1755-8794-2-15  0.46
2008 Guimbellot JS, Fortenberry JA, Siegal GP, Moore B, Wen H, Venglarik C, Chen YF, Oparil S, Sorscher EJ, Hong JS. Role of oxygen availability in CFTR expression and function. American Journal of Respiratory Cell and Molecular Biology. 39: 514-21. PMID 18474670 DOI: 10.1165/Rcmb.2007-0452Oc  0.531
2004 Varga K, Jurkuvenaite A, Wakefield J, Hong JS, Guimbellot JS, Venglarik CJ, Niraj A, Mazur M, Sorscher EJ, Collawn JF, Bebök Z. Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines. The Journal of Biological Chemistry. 279: 22578-84. PMID 15066992 DOI: 10.1074/Jbc.M401522200  0.516
Low-probability matches (unlikely to be authored by this person)
2003 Zwerner JP, Guimbellot J, May WA. EWS/FLI function varies in different cellular backgrounds. Experimental Cell Research. 290: 414-419. PMID 14567998 DOI: 10.1016/S0014-4827(03)00371-9  0.285
2018 Guimbellot JS, Acosta EP, Rowe SM. Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducer. Pediatric Pulmonology. PMID 29488691 DOI: 10.1002/Ppul.23971  0.264
2023 Young D, Bartlett LE, Guimbellot J, Milinic T, Burdis N, Gill ER, Lease ED, Goss CH, Kapnadak SG, Ramos KJ. Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37798159 DOI: 10.1016/j.jcf.2023.09.017  0.259
2021 Anderson JD, Liu Z, Odom LV, Kersh L, Guimbellot JS. CFTR Function and Clinical Response to Modulators Parallel Nasal Epithelial Organoid Swelling. American Journal of Physiology. Lung Cellular and Molecular Physiology. PMID 34009038 DOI: 10.1152/ajplung.00639.2020  0.252
2023 Li C, Liu Z, Anderson J, Liu Z, Tang L, Li Y, Peng N, Chen J, Liu X, Fu L, Townes TM, Rowe SM, Bedwell DM, Guimbellot J, Zhao R. Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells. Plos One. 18: e0295009. PMID 38019847 DOI: 10.1371/journal.pone.0295009  0.249
2018 Sanders CD, Guimbellot JS, Muhlebach MS, Lin FC, Gilligan P, Esther CR. Tracheostomy in children: Epidemiology and clinical outcomes. Pediatric Pulmonology. PMID 29968973 DOI: 10.1002/Ppul.24071  0.233
2022 Ramos KJ, Guimbellot JS, Valapour M, Bartlett LE, Wai TH, Goss CH, Pilewski JM, Faro A, Diamond JM. Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35474016 DOI: 10.1016/j.jcf.2022.04.009  0.22
2021 Smith M, Ryan KJ, Gutierrez H, Sanchez LHG, Anderson JN, Acosta EP, Benner KW, Guimbellot JS. Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 34130909 DOI: 10.1016/j.jcf.2021.05.008  0.206
2022 Guimbellot JS, Nichols DP, Brewington JJ. Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis. Clinics in Chest Medicine. 43: 617-630. PMID 36344070 DOI: 10.1016/j.ccm.2022.06.005  0.184
2022 Guimbellot JS, Ryan KJ, Anderson JD, Parker KL, Victoria Odom L, Rowe SM, Acosta EP. Plasma and cellular ivacaftor concentrations in patients with CF. Pediatric Pulmonology. PMID 35927224 DOI: 10.1002/ppul.26093  0.177
2021 Guimbellot JS, Taylor-Cousar JL. Combination CFTR modulator therapy in children and adults with cystic fibrosis. The Lancet. Respiratory Medicine. PMID 33965001 DOI: 10.1016/S2213-2600(21)00176-4  0.17
2023 Gunnett MA, Baker E, Mims C, Self ST, Gutierrez HH, Guimbellot JS. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome. Frontiers in Pediatrics. 11: 1127659. PMID 36969284 DOI: 10.3389/fped.2023.1127659  0.164
2019 Secunda KE, Guimbellot JS, Jovanovic B, Heltshe SL, Sagel SD, Rowe SM, Jain M. Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared to Males. American Journal of Respiratory and Critical Care Medicine. PMID 31841644 DOI: 10.1164/rccm.201909-1845LE  0.146
2023 Oates GR, Mims C, Geurs R, Bergquist R, Hager A, Guimbellot JS, Hartzes AM, Gutierrez HH. Mobile health platform for self-management of pediatric cystic fibrosis: Impact on patient-centered care outcomes. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37085386 DOI: 10.1016/j.jcf.2023.04.009  0.145
2023 Anderson JD, Davis BH, Giang G, Jones A, Lee CR, Parker K, Searcy H, Benner K, Limdi NA, Guimbellot JS. Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis. Clinical and Translational Science. PMID 36760155 DOI: 10.1111/cts.13479  0.138
2023 Oates GR, Lock L, Tarn V, Geurs R, Guimbellot JS, Baker E, Magruder T. Electronic screening for unmet social needs in a pediatric pulmonary clinic: Acceptability and associations with health outcomes. Pediatric Pulmonology. PMID 36721912 DOI: 10.1002/ppul.26339  0.109
2022 Ryan KJ, Guimbellot JS, Dowell AE, Reed-Walker KD, Kerstner-Wood CD, Anderson JD, Liu Z, Acosta EP. Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1213: 123518. PMID 36371965 DOI: 10.1016/j.jchromb.2022.123518  0.108
2001 Fitzgerald DA, Guimbellot JS. Peptides, made to order Scientist. 15: 25-26.  0.013
2001 Fitzgerald DA, Guimbellot JS. Tailored arrays Scientist. 15: 26-28.  0.01
Hide low-probability matches.